Castle Biosciences (CSTL) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free CSTL Stock Alerts $19.86 -0.20 (-1.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKnights of Columbus Asset Advisors LLC Has $2.29 Million Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)marketbeat.com - April 21 at 6:39 AMKornitzer Capital Management Inc. KS Trims Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)marketbeat.com - April 20 at 11:18 AMDerek J. Maetzold Sells 1,947 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) Stockamericanbankingnews.com - April 19 at 5:44 AMCastle Biosciences CEO sells over $100k in company stockinvesting.com - April 18 at 3:11 PMInsider Selling: Castle Biosciences, Inc. (NASDAQ:CSTL) Insider Sells 1,947 Shares of Stockinsidertrades.com - April 18 at 6:49 AMCastle Biosciences, Inc. (NASDAQ:CSTL) Insider Sells $39,621.45 in Stockmarketbeat.com - April 17 at 3:39 PMWe're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burnfinance.yahoo.com - April 17 at 7:42 AMCastle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024businesswire.com - April 11 at 7:00 AMCastle Biosciences, Inc. (NASDAQ:CSTL) Director Daniel Bradbury Sells 2,400 Sharesinsidertrades.com - April 11 at 6:48 AMCastle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborationsfinance.yahoo.com - April 10 at 6:03 PMCastle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborationsbusinesswire.com - April 10 at 5:00 PMCastle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Yearfinance.yahoo.com - April 10 at 8:02 AMCastle Biosciences' Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Yearbusinesswire.com - April 10 at 7:00 AMCastle Biosciences director sells over $440k in company stockinvesting.com - April 10 at 1:48 AMCastle Biosciences, Inc. (NASDAQ:CSTL) Director Daniel Bradbury Sells 9,152 Sharesinsidertrades.com - April 9 at 4:32 AMTritonpoint Wealth LLC Buys Shares of 94,356 Castle Biosciences, Inc. (NASDAQ:CSTL)marketbeat.com - April 6 at 11:50 AMInsider Selling: Castle Biosciences, Inc. (NASDAQ:CSTL) Insider Sells 2,368 Shares of Stockinsidertrades.com - April 6 at 7:54 AMCastle Biosciences, Inc. (NASDAQ:CSTL) Insider Sells $51,385.60 in Stockmarketbeat.com - April 5 at 6:47 PMWhat Makes Castle Bioscience (CSTL) a Prospective Investment?finance.yahoo.com - April 5 at 11:08 AMPresentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancerfinance.yahoo.com - April 4 at 6:11 PMPresentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancerbusinesswire.com - April 4 at 4:30 PMCastle Biosciences, Inc. (NASDAQ:CSTL) Sees Significant Increase in Short Interestmarketbeat.com - March 31 at 7:59 PMCastle Biosciences Announces Updates to its Board of Directorsbusinesswire.com - March 27 at 5:00 PMCastle Biosciences (NASDAQ:CSTL) Shares Up 5.4%marketbeat.com - March 26 at 4:46 PMCastle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Yearfinance.yahoo.com - March 25 at 9:20 AMDerek J. Maetzold Sells 2,295 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) Stockinsidertrades.com - March 24 at 6:16 AMCastle Biosciences, Inc. (NASDAQ:CSTL) Insider Derek J. Maetzold Sells 2,295 Sharesmarketbeat.com - March 22 at 8:35 PMLong-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNBbusinesswire.com - March 22 at 4:30 PMDoes Castle Bioscience (CSTL) Have Robust Growth Prospects?finance.yahoo.com - March 20 at 9:52 AMLeading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapybusinesswire.com - March 19 at 7:00 AMWalleye Capital LLC Buys Shares of 170,786 Castle Biosciences, Inc. (NASDAQ:CSTL)marketbeat.com - March 17 at 4:20 AMDerek J. Maetzold Sells 4,131 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) Stockinsidertrades.com - March 16 at 10:16 AMCSTL Apr 2024 17.500 callfinance.yahoo.com - March 16 at 1:01 AMNew Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Olderfinance.yahoo.com - March 15 at 8:01 PMNew Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences' IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Olderbusinesswire.com - March 15 at 4:30 PMBio-Techne and Qiagen had the biggest increase in short interest levels last month - Bairdseekingalpha.com - March 13 at 2:56 PMJacobs Levy Equity Management Inc. Has $9.25 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL)marketbeat.com - March 13 at 6:56 AMCastle Biosciences Inc CSTLmorningstar.com - March 12 at 6:58 PMCastle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forumbusinesswire.com - March 12 at 7:00 AMCastle Biosciences, Inc. (NASDAQ:CSTL) Insider Sells $49,266.44 in Stockinsidertrades.com - March 12 at 5:20 AMCastle Biosciences, Inc. (NASDAQ:CSTL) Insider Derek J. Maetzold Sells 2,372 Sharesmarketbeat.com - March 11 at 7:47 PMCastle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meetingbusinesswire.com - March 8 at 4:30 PMSchonfeld Strategic Advisors LLC Purchases 110,500 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)marketbeat.com - March 8 at 6:11 AMCastle Biosciences (NASDAQ:CSTL) Shares Down 3% Following Insider Sellingmarketbeat.com - March 7 at 10:31 AMIn Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroupsbusinesswire.com - March 7 at 7:00 AMCastle Biosciences, Inc. (NASDAQ:CSTL) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimatesfinance.yahoo.com - March 2 at 9:02 AMKeyCorp Increases Castle Biosciences (NASDAQ:CSTL) Price Target to $28.00marketbeat.com - March 1 at 3:39 PMCastle Biosciences (NASDAQ:CSTL) Shares Gap Up to $18.06marketbeat.com - March 1 at 11:40 AMCastle Biosciences, Inc. (CSTL) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 1 at 10:11 AMOutperform Rating for Castle Biosciences Amid Strong Market Presence and Growth Prospectsmarkets.businessinsider.com - March 1 at 10:11 AM Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Your Money is Not Safe (Ad)Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below… CLICK HERE TO GET YOUR GUIDE NOW CSTL Media Mentions By Week CSTL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSTL News Sentiment▼0.890.44▲Average Medical News Sentiment CSTL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSTL Articles This Week▼54▲CSTL Articles Average Week Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Fulgent Genetics News CareDx News Sera Prognostics News Genetron News Biodesix News Viridian Therapeutics News Personalis News Renalytix News Exagen News DermTech News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CSTL) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
